TG Therapeutics
IPOPublic · New York, United States · $25.0M raised
- Headquarters
- New York, New York
- Employees
- 201–500
- Business Model
- B2B
- Website
- tgtherapeutics.com
- Total Funding
- $25.0M
- Last Round
- $25.0M Private EquityFeb 2012
- Rounds
- 1
- Type
- Public
About
Biopharmaceutical company developing treatments for B-cell malignancies and autoimmune diseases in oncology and hematology.
Summary
TG Therapeutics is a Biotech company based in New York, United States. It has raised $25.0M in total across 1 round, most recently a $25.0M Private Equity round in Feb 2012. Investors include Blue Owl Capital.
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Mar 2026
Sign up to see all 3 rounds
IPO through Debt Financing — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/tg-therapeutics"><img src="https://indexed.vc/api/badge/company/tg-therapeutics" alt="TG Therapeutics on Indexed.vc" width="260" height="76" /></a>